Solazyme,
Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, and
maker of the skincare brand, Algenist®,
today announced that the line has won the prestigious 2014 Marie Claire
Prix d’ Excellence de la Beauté in France. The award, which was
presented at the Les Prix d’Excellence de la Beauté Marie Claire 2014
annual event, honors exceptional advancements in innovation, efficacy,
texture, design, and communication of cosmetic brands. A robust panel of
French and international beauty journalists, presided by Ariane Goldet,
the renowned Health and Beauty Editor of Marie Claire France, judged the
competition, which included hundreds of product and brand entries.
Algenist is one of only two US brands to win a prize at the 2014 awards,
and was unanimously selected by the judging panel.
“Algenist delivers cutting-edge, scientific innovation based on the
incredible regenerative powers of microalgae, providing visible results
that demonstrate significant anti-aging properties,” said Frederic
Stoeckel, SVP & General Manager, Solazyme Health Sciences, in accepting
the award. “Algenist is proud to be delivering un-matched product
efficacy to consumers and we are honored to be recognized for these
advancements by this esteemed panel of judges and Marie Claire.”
“Algenist is one of today’s leading skincare brands that encompasses
discovery, innovation, and importantly, results,” said Ariane Goldet,
Health and Beauty Editor, Marie Claire. “For the past 28 years, we have
searched for trailblazing products and brands that couple the latest
breakthroughs with the latest trends, and Algenist with their
breakthrough, hero-ingredients, Alguronic Acid® and
Microalgae Oil, do all of this and more. They are a pioneering brand and
we are pleased to place them amongst the 2014 Maria Claire Prix d’
Excellence de la Beauté winners.”
Harnessing the genius of microalgae and based on two potent ingredients
including patented Alguronic
Acid and Microalgae
Oil, Algenist is a skincare brand rooted in biotechnology expertise.
The award-winning line can be viewed in the February 2014 edition of
Marie Claire France.
Follow Us Online:
About Algenist
Algenist is an award-winning skincare brand harnessing the remarkable
regenerative properties of microalgae and rooted in breakthrough
biotechnology innovation. After a dedicated team of scientists
originally tasked with researching renewable energy solutions discovered
Alguronic Acid® (patented), a powerful regenerative compound
produced by microalgae that functions to protect and regenerate the
single-celled organism in harsh environmental conditions, it has since
become a principal ingredient in many of Algenist’s prestige products.
The line has since expanded to tap many of the additional benefits
brought forth by this remarkable organism and today, the brand remains
dedicated to using groundbreaking science to formulate revolutionary
skincare innovations poised for any skin type at any age. Committed to
proven results, Alguronic Acid and Microalgae Oil have undergone 3rd
party clinical testing for scientifically-based efficacy claims. All
Algenist products are consumer and dermatologist-tested,
non-comedogenic, and hypoallergenic.
About Solazyme
Solazyme, Inc. (SZYM) is a renewable oil and bioproducts company that
transforms a range of low-cost plant-based sugars into high-value oils
and food ingredients. Headquartered in South San Francisco, Solazyme's
renewable products can replace or enhance oils derived from the world's
three existing sources — petroleum, plants and animal fats. Initially,
Solazyme is focused on commercializing its products into three target
markets: (1) chemicals and fuels, (2) nutrition and (3) skin and
personal care.
Solazyme®, Algenist®, Alguronic Acid®
and the Solazyme logo are registered trademarks of Solazyme, Inc.
This press release contains certain forward-looking statements about
Algenist and Solazyme, including statements that involve risks and
uncertainties concerning: the attributes of the product; and the results
achieved from product use. When used in this press release, the words
“will”, “expects”, “intends” and other similar expressions and any other
statements that are not historical facts are intended to identify those
assertions as forward-looking statements. Any such statement may be
influenced by a variety of factors, many of which are beyond the control
of Solazyme, that could cause actual outcomes and results to be
materially different from those projected, described, expressed or
implied in this press release due to a number of risks and
uncertainties. Potential risks and uncertainties include, among others:
Algenist and Solazyme’s limited history in commercializing products;
implementation risk in deploying new technologies and market acceptance
of its products. Accordingly, no assurances can be given that any of the
events anticipated by the forward-looking statements will transpire or
occur, or if any of them do so, what impact they will have on the
results of operations or financial condition of Solazyme.
In addition, please refer to the documents that Solazyme, Inc. files
with the Securities and Exchange Commission, including its Quarterly
Reports on Form 10-Q, as updated from time to time, for a discussion of
these and other risks. You are cautioned not to place undue reliance on
forward-looking statements, which speak only as of the date of this
press release. Solazyme is not under any duty to update any of the
information in this press release.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140121005334/en/
Copyright Business Wire 2014